Accelerated partial breast irradiation (APBI) is a new treatment delivery technique that decreases overall treatment time by using higher fractional doses than conventional fractionation. Here, a quantitative analysis study of CyberKnife-based APBI was performed on 10 patients with leftsided breast cancer who had already finished conventional treatment at the Inha University Hospital. Dosimetric parameters for four kinds of treatment plans (3D-CRT, IMRT, VMAT, and CyberKnife) were analyzed and compared with constraints in the NSABP B39/RTOG 0413 protocol and a published CyberKnife-based APBI study. For the 10 patients recruited in this study, all the dosimetric parameters, including target coverage and doses to normal structures, met the NSABP B39/RTOG 0413 protocol. Compared with other treatment plans, a more conformal dose to the target and better dose sparing of critical structures were observed in CyberKnife plans. Accelerated partial breast irradiation via CyberKnife is a suitable treatment delivery technique for partial breast irradiation and offers improvements over external beam APBI techniques.
Introduction
Breast-conserving therapy (BCT) is the preferred treatment for early-stage breast cancer, and numerous published studies have shown that equivalent overall survival between patients who received breast-conserving surgery with whole breast irradiation (WBI) and patients treated by mastectomy alone. These studies demonstrate a 70% reduction in local recurrence, with the addition of adjuvant radiation after breast-conserving surgery. 1, 2) However, researchers have estimated that up to 25% of patients have not received adjuvant radiation therapy after breast conservation surgery. 3) Prolonged treatment time, cost, distance to treatment facilities, and patient inconvenience have been implicated as possible deterrents to BCT. 4, 5) Accelerated partial breast irradiation (APBI) is a new treatment delivery technique that decreased overall treatment time by using higher fractional doses than conventional fractionation. As opposed to whole breast irradiation, the dose is only given to the resection volume. Various techniques have been tried and complete reviews of APBI techniques can be found in the literature. 6, 7) Applying to three-dimensional conformal radiation therapy (3D-CRT) and the NASBP B-39/RTOG0413 dose guidelines, Hepel et al. 8) found a severe late toxicity in six of 60 patients who were treated with APBI. Recht et al. 9) observed a higher risk of pneumonitis in patients with APBI who were treated with 3D-CRT. In other to reduce the dose to organs at risk (OAR), other treatment modalities have been used for APBI, including intensity modulated radia-74 www.ksmp.or.kr tion therapy (IMRT), tomotherapy, and proton therapy.
IMRT showed improved ipsilateral breast and other normal tissue dose sparing compared with 3D-CRT, with very low acute toxicity. 10) Tomotherapy also reduced the dose to ipsilateral breast tissue, but at the cost of considerable increases in lung and heart doses. Protons have proven dosimetrically superior to all these techniques, but their availability is limited to a few centers globally. 11) A frameless robotic stereotactic radiosurgery system, the CyberKnife (Accuray Incorporated, Sunnyvale, CA, USA) provides image-guidance for the continuous tracking of target motion during respiration and patient movement.
In the context of APBI, the Cyberknife could spare nontarget breast tissue volume (NTBTV) more efficiently and potentially, which allows more agreeable cosmetic outcomes due to the combination of non-coplanar fields with tracking of the target volume. Indeed, researchers at the University of Texas Southwestern Medical found that APBI treatment plans achieved highly conformal target coverage with sparing doses to OAR, relative to 3D-CRT plans. 12 
) Fox
Chase's treatment planning study has come to a similar conclusion as improving the boost dose distribution produced by CyberKnife. 13) Here, a quantitative analysis study of CyberKnife-based APBI was performed on 10 patients with left-sided breast cancer who had already finished conventional treatment at the Inha University Hospital.
Materials and Methods

Patient selection
After Institutional Review Board (IRB) approval was obtained, 10 previously treated patients with left-sided breast cancer were selected for our retrospective study. Patients for CyberKnife-based APBI were selected over 50 years of age with stage I and II histologically-confirmed invasive non-lobular carcinoma or ductal carcinoma in situ (DCIS).
All patients were treated with 50.4 Gy in 28 fractions, in a conventional fractionation. Further patient details are listed in Table 1 . The OAR considered in this study were ipsilateral, contralateral breast, ipsilateral, contralateral lung, heart, thyroid, chest wall, and skin.
Acquisition and definition of treatment volumes
Delineation and treatment planning
The CT images were exported to Eclipse treatment planning system (Version 8.6) and MultiPlan treatment planning system (Version 2.2.0). The Phase III NSABP B39/ RTOG 0413 partial breast protocol was followed for structure delineation and planning. The structures contoured for planning were the lumpectomy cavity or GTV, CTV, PTV, ipsilateral, contralateral breast, ipsilateral, contralateral lung, and heart. The eclipse-planned technique were 3D-CRT, IMRT, and volumetric modulated arc therapy (VMAT).
The 3D-CRT and IMRT plans were generated using a 5-field and 4-field coplanar technique, respectively. The VMAT plans were generated using RapidArc with anisotropic analytical algorithm (AAA). A double partial arc of 180° to 200° around the treated breast was used. The Cy-berKnife plans were generated using the iterative optimization mode to achieve the optimal dose to the target and normal structures. We used the fiducial marker tracking method. Prior to treatment, four 2-mm gold fiducials were implanted around the lumpectomy site under ultrasound guidance by a single board-certified radiologist. Depending on the size of the tumor, 1-2 fixed collimator ranging from 10 to 15 mm were chosen. Approximately, 95% of the PTV was to receive 100% of the prescription dose. All plans were generated to deliver 30 Gy in five fractions to the PTV over consecutive days.
Dosimetric parameters for plan comparison
For all treatment plans, dosimetric parameters calculated for the OARs are listed in 
Results and Discussion
For the 10 patients recruited in this study, all the dosimetric parameters, including target coverage and doses to normal structures, met the NSABP B39/RTOG 0413 protocol, except for the contralateral breast maximum dose constraint as shown in Table 3 . The PTV coverage requirement in the protocol is V 90% >90%, which means that the percentage volume receiving 90% of the prescription dose should be greater than 90%. In our study, the mean percentage volume covering 100% of the prescription dose was 96.5±0.7%, which was more conformal than the target dose required in the protocol. The average CI for all Table 4 . Dosimetric data from CyberKnife studies were very close for the ipsilateral and contralateral breast and the ipsilateral and contralateral lungs. However, in our planning study, the mean V 1.5 Gy doses to the heart were lower than those of the published data.
Our quantitative analysis study results is superior to the previously published work from Xu et al., 15) who showed the feasibility of using the CyberKnife for APBI. Their work proposed the dosimetric comparison of treatment plans Fig. 1 for all treatment techniques. Dosimetric data for the contralateral breast and contralateral lung between techniques are very similar. In contrast, as shown in Fig. 1a, 1c As such, we believe that the steep dose gradients that are characteristic of CyberKnife APBI will allow more than acceptable cosmetic results and low toxicity over the longterm.
Conclusion
For the 10 patients who were recruited in this study, all the dosimetric parameters, including target coverage, and doses to normal structures, met the NSABP B39/RTOG 0413 protocol. Compared to other treatment plans, a more conformal dose to the target and better dose sparing of critical structures were observed in CyberKnife plans.
Accelerated partial breast irradiation via CyberKnife is a suitable tretment delivery technique for partial breast irradiation and offers improvements over external beam APBI techniques.
